SK173197A3 - Nucleic acid molecule - Google Patents

Nucleic acid molecule Download PDF

Info

Publication number
SK173197A3
SK173197A3 SK1731-97A SK173197A SK173197A3 SK 173197 A3 SK173197 A3 SK 173197A3 SK 173197 A SK173197 A SK 173197A SK 173197 A3 SK173197 A3 SK 173197A3
Authority
SK
Slovakia
Prior art keywords
polypeptide
nucleic acid
acid molecule
mistletoe
dimer
Prior art date
Application number
SK1731-97A
Other languages
English (en)
Slovak (sk)
Inventor
Hans Lentzen
Jurgen Eck
Axel Baur
Holger Zinke
Original Assignee
Madaus Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus Ag filed Critical Madaus Ag
Publication of SK173197A3 publication Critical patent/SK173197A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6819—Plant toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SK1731-97A 1995-06-26 1996-06-25 Nucleic acid molecule SK173197A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95109949A EP0751221B1 (de) 1995-06-26 1995-06-26 Rekombinantes Mistellektin (rML)
PCT/EP1996/002773 WO1997001636A2 (de) 1995-06-26 1996-06-25 REKOMBINANTES MISTELLEKTIN (rML)

Publications (1)

Publication Number Publication Date
SK173197A3 true SK173197A3 (en) 1999-01-11

Family

ID=8219389

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1731-97A SK173197A3 (en) 1995-06-26 1996-06-25 Nucleic acid molecule

Country Status (21)

Country Link
US (1) US6271368B1 (pt)
EP (3) EP0884388A1 (pt)
JP (2) JP3291548B2 (pt)
KR (1) KR100292918B1 (pt)
CN (1) CN1160457C (pt)
AR (1) AR003961A1 (pt)
AT (1) ATE170922T1 (pt)
AU (1) AU719297B2 (pt)
BR (1) BR9609223A (pt)
CA (1) CA2225924C (pt)
CZ (1) CZ292689B6 (pt)
DE (1) DE59503524D1 (pt)
DK (1) DK0751221T3 (pt)
ES (1) ES2124470T3 (pt)
HU (1) HU225738B1 (pt)
NO (1) NO327165B1 (pt)
PL (1) PL193281B1 (pt)
RU (1) RU2241750C2 (pt)
SK (1) SK173197A3 (pt)
WO (1) WO1997001636A2 (pt)
ZA (1) ZA965361B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1012256T3 (da) * 1997-01-02 2004-07-12 Viscum Ag Rekombinante fusionsproteiner på basis af ribosom-inaktiverende proteiner fra misteltenen Viscum album
CN1104438C (zh) * 1997-06-02 2003-04-02 山东医科大学附属医院 槲寄生提取物及其用途
DE19804210A1 (de) * 1998-02-03 1999-08-12 Biosyn Arzneimittel Gmbh Rekombinante Mistellektine
KR20010011330A (ko) * 1999-07-27 2001-02-15 김종배 한국산 겨우살이 추출물과 이로부터 분리한 단백질 및 상기 단백질에서 분리한 렉틴
DE10044027A1 (de) * 2000-09-06 2002-03-14 Viscum Ag Rekombinant erzeugtes Mistellektin (ML III)
NZ526202A (en) * 2000-11-14 2005-08-26 Ian Pryme Orally ingestible preparation of mistletoe lectins, ML-I, ML-II and ML-III and methods fro treating cancer and autoimmune diseases
DE60220068T2 (de) 2001-07-09 2008-01-24 University Of Copenhagen Verfahren und ableger für die massenvermehrung von pflanzenparasiten
DE10149030A1 (de) 2001-10-05 2003-04-10 Viscum Ag Stabile galenische gefriergetrocknete Arzneimittelzubereitung von rViscumin
ATE362106T1 (de) * 2001-12-21 2007-06-15 Viscum Ag Verfahren zur bestimmung der responsivität eines individuums für mistellektin
DE102011003478A1 (de) * 2011-02-01 2012-08-02 Cytavis Biopharma Gmbh Antivirales Mittel enthaltend rekombinante Mistellektine
EP2508195A1 (de) * 2011-04-06 2012-10-10 Cytavis BioPharma GmbH Arzneimittel enthaltend rekombinante Mistellektine zur Behandlung des malignen Melanoms
EP2723374B1 (de) * 2011-06-27 2017-09-06 Melema Pharma GmbH Rekombinantes mistellektin und dessen verwendung als adjuvans
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
EP3205348A1 (de) 2016-02-15 2017-08-16 Melema Pharma GmbH Arzneimittel enthaltend rekombinante mistellektine zur behandlung von hirntumoren
CN106166223A (zh) * 2016-09-17 2016-11-30 四川易创生物科技有限公司 一种治疗肺肾阴亏、潮热盗汗的中药组合物及其制备方法
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
CN115025207B (zh) * 2022-06-23 2023-02-07 黑龙江中医药大学 一种用于治疗类风湿性关节炎的药物及其制备方法
CN117924453B (zh) * 2024-03-19 2024-08-06 广东现代汉方科技有限公司 一种甘露糖特异性凝集素重组植物蛋白的制备方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127532A (en) * 1989-09-12 2000-10-03 Board Of Trustees Operating Michigan State University Lectin cDNA and transgenic plants derived therefrom
US5407454A (en) * 1989-11-07 1995-04-18 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
DE4221836A1 (de) 1992-07-03 1994-01-05 Gabius Hans Joachim Prof Dr Das biochemisch aufgereinigte Mistel-Lektin (ML-1) als therapeutisch anwendbarer Immunmodulator
DE4341476A1 (de) * 1993-12-02 1995-06-08 Uwe Dr Pfueller Mittel zur Untersuchung und Beeinflussung zellulärer Veränderungen auf Lektinbasis

Also Published As

Publication number Publication date
WO1997001636A3 (de) 1997-03-27
EP0835312A2 (de) 1998-04-15
HUP9900316A2 (hu) 1999-05-28
AU719297B2 (en) 2000-05-04
WO1997001636A2 (de) 1997-01-16
PL193281B1 (pl) 2007-01-31
ZA965361B (en) 1997-08-27
HUP9900316A3 (en) 2002-07-29
EP0751221A1 (de) 1997-01-02
CZ292689B6 (cs) 2003-11-12
NO327165B1 (no) 2009-05-04
RU2241750C2 (ru) 2004-12-10
DK0751221T3 (da) 1999-06-07
US6271368B1 (en) 2001-08-07
EP0884388A1 (de) 1998-12-16
KR100292918B1 (ko) 2001-06-15
CA2225924C (en) 2008-10-28
NO976058L (no) 1998-02-03
KR19990028570A (ko) 1999-04-15
AU6416396A (en) 1997-01-30
CN1160457C (zh) 2004-08-04
ES2124470T3 (es) 1999-02-01
DE59503524D1 (de) 1998-10-15
ATE170922T1 (de) 1998-09-15
AR003961A1 (es) 1998-09-30
CN1192240A (zh) 1998-09-02
CZ404997A3 (cs) 1998-06-17
JP3291548B2 (ja) 2002-06-10
HU225738B1 (en) 2007-07-30
EP0751221B1 (de) 1998-09-09
CA2225924A1 (en) 1997-01-16
NO976058D0 (no) 1997-12-23
JP2002300890A (ja) 2002-10-15
MX9710522A (es) 1998-08-30
BR9609223A (pt) 1999-05-11
JPH10508206A (ja) 1998-08-18
PL324209A1 (en) 1998-05-11

Similar Documents

Publication Publication Date Title
SK173197A3 (en) Nucleic acid molecule
Tsaneva et al. 130 years of plant lectin research
TWI649423B (zh) 抗發炎胜肽及包含其之成分（二）
Eck et al. Cloning of the mistletoe lectin gene and characterization of the recombinant A‐chain
Eck et al. Characterization of recombinant and plant‐derived mistletoe lectin and their B‐chains
Büssing Induction of apoptosis by the mistletoe lectins: a review on the mechanisms of cytotoxicity mediated by Viscum album L.
US6008324A (en) Non-toxic ribosome inactivating proteins (RIPs) with two chains, process for the preparation thereof and applications
SinghBains et al. Mitogenic and anti-proliferative activity of a lectin from the tubers of Voodoo lily (Sauromatum venosum)
Voss et al. Identification and characterization of riproximin, a new type II ribosome‐inactivating protein with antineoplastic activity from Ximenia americana
EP3003350B1 (en) Targeted modulation of macrophages
Rezaei-Moshaei et al. Recombinant pebulin protein, a type 2 ribosome-inactivating protein isolated from dwarf elder (Sambucus ebulus L.) shows anticancer and antifungal activities in vitro
Stirpe et al. Characterization of highly toxic type 2 ribosome-inactivating proteins from Adenia lanceolata and Adenia stenodactyla (Passifloraceae)
KR20040077669A (ko) 선천 면역의 작동체
Gawlak et al. Molecular, biological, and preliminary structural analysis of recombinant bryodin 1, a ribosome-inactivating protein from the plant Bryonia dioica
Mi et al. Trichomislin, a novel ribosome-inactivating protein, induces apoptosis that involves mitochondria and caspase-3
KR101254004B1 (ko) 세포 투과성 설피레독신 융합 단백질을 포함하는 염증 예방 및 치료용 조성물
MXPA97010522A (es) Lectina de muerdago recombinante (rml)
EP1846441B1 (en) Riproximin , a novel type ii ribosome-inactivating protein and uses thereof
FAI Studies on ribosome-inactivating proteins from momordica charantia